Edwards Lifesciences stock rose slightly late Tuesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback